Catherine Mazzella
Family · Orlando, FLNPI 1477018935
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,791 of the $3,176 with a category attached, or 87.9%. It is spread thinly across 32 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations.
Across 146 payments — averaging $21.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$459
- Novartis$361
- Johnson & Johnson$357
- Merck$191
- Daiichi Sankyo Inc.$157
- AstraZeneca$155
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,79188%
- Education$38512%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 20 | $459 |
| Novartis | 18 | $361 |
| Johnson & Johnson(2 entities) | 14 | $357 |
| Merck | 10 | $191 |
| Daiichi Sankyo Inc. | 8 | $157 |
| AstraZeneca(2 entities) | 8 | $155 |
| Astellas Pharma US Inc | 4 | $150 |
| Lilly USA, LLC | 7 | $135 |
| Sanofi | 5 | $113 |
| Pfizer | 4 | $99 |
| Sanofi-aventis U.S. LLC | 1 | $87 |
| Seagen Inc. | 4 | $80 |
| Dova Pharmaceuticals | 4 | $77 |
| Bayer | 4 | $71 |
| Eisai Inc. | 4 | $69 |
| Regeneron Healthcare Solutions, Inc. | 3 | $68 |
| Jazz Pharmaceuticals Inc. | 4 | $67 |
| Coherus Oncology, Inc. | 2 | $61 |
| Puma Biotechnology, Inc. | 3 | $54 |
| Taiho Oncology, Inc. | 3 | $52 |
| Abiomed | 1 | $39 |
| Sobi, Inc | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Morphosys, US Inc. | 2 | $30 |
| Myovant Sciences Inc. | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $23 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $22 |
| Array Biopharma Inc | 1 | $22 |
| CTI Biopharma Corp. | 1 | $22 |
| Baxter Healthcare | 1 | $19 |
| Epizyme, Inc. | 1 | $17 |
How this compares
$3,176 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Other family in Orlando
- Donna OrtizOrlando$417K
- Lindsey McCabeOrlando$37K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.